CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 122 filers reported holding CONSTELLATION PHARMCETICLS I in Q3 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,111,000 | -18.8% | 90,259 | 0.0% | 0.00% | – |
| Q4 2020 | $2,599,000 | -67.5% | 90,259 | -77.1% | 0.00% | -100.0% |
| Q3 2020 | $7,998,000 | -62.4% | 394,764 | -44.3% | 0.00% | -50.0% |
| Q2 2020 | $21,283,000 | -49.3% | 708,257 | -46.9% | 0.00% | -66.7% |
| Q1 2020 | $41,952,000 | -43.7% | 1,334,764 | -15.6% | 0.01% | -25.0% |
| Q4 2019 | $74,515,000 | +915.9% | 1,581,715 | +39.3% | 0.01% | +700.0% |
| Q3 2019 | $7,335,000 | -56.5% | 1,135,387 | -17.4% | 0.00% | -50.0% |
| Q2 2019 | $16,878,000 | -20.9% | 1,374,464 | -12.7% | 0.00% | -33.3% |
| Q1 2019 | $21,331,000 | +247.9% | 1,574,245 | -0.0% | 0.00% | +200.0% |
| Q4 2018 | $6,131,000 | -40.4% | 1,574,445 | -2.7% | 0.00% | 0.0% |
| Q3 2018 | $10,281,000 | – | 1,618,545 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $37,259,000 | 42.17% |
| Svennilson Peter | 4,677,939 | $57,446,000 | 16.42% |
| VHCP Management II, LLC | 726,677 | $8,924,000 | 2.81% |
| Casdin Capital, LLC | 1,523,960 | $18,714,229,000 | 1.75% |
| P.A.W. CAPITAL CORP | 120,000 | $1,474,000 | 1.59% |
| Cormorant Asset Management, LP | 1,271,685 | $15,616,000 | 0.90% |
| VHCP Management III, LLC | 66,667 | $819,000 | 0.38% |
| Orbimed Advisors | 835,842 | $10,264,000 | 0.16% |
| Hillhouse Capital Management | 317,921 | $3,904,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 183,600 | $2,255,000 | 0.08% |